Filing Details
- Accession Number:
- 0001127602-19-030734
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-17 16:46:37
- Reporting Period:
- 2019-10-15
- Accepted Time:
- 2019-10-17 16:46:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441876 | Mostafa Ronaghi | 5200 Illumina Way San Diego CA 92122 | Svp & Cto | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-15 | 4,000 | $69.34 | 80,585 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-10-15 | 1,210 | $309.89 | 79,375 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-10-15 | 1,296 | $310.74 | 78,079 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-10-15 | 1,394 | $311.86 | 76,685 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-10-15 | 100 | $312.87 | 76,585 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-10-15 | 4,000 | $0.00 | 4,000 | $69.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-02-28 | 2021-01-31 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 1,210 shares sold ranging from $309.15 to $310.14 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,296 shares sold ranging from $310.43 to $311.09 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,394 shares sold ranging from $311.43 to $312.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
